BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15735726)

  • 1. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.
    Wang W; Huper G; Guo Y; Murphy SK; Olson JA; Marks JR
    Oncogene; 2005 Apr; 24(16):2705-14. PubMed ID: 15735726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
    Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
    Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
    Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
    Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines.
    Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G
    Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.
    Sato N; Fukushima N; Maitra A; Matsubayashi H; Yeo CJ; Cameron JL; Hruban RH; Goggins M
    Cancer Res; 2003 Jul; 63(13):3735-42. PubMed ID: 12839967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
    Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
    Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines.
    Pilat MJ; Schwab ED; Yao KL; Pienta KJ
    Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
    Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
    Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
    Huper G; Marks JR
    Cancer Res; 2007 Apr; 67(7):2990-3001. PubMed ID: 17409405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
    Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
    Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D2 expression in familial and sporadic breast cancer.
    Fischer H; Chen J; Skoog L; Lindblom A
    Oncol Rep; 2002; 9(6):1157-61. PubMed ID: 12375011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.